An Update from Our Firm about COVID-19

Abraham, Watkins, Nichols, Sorrels, Agosto, Aziz & Stogner remains fully operational and committed to serving our clients and colleagues throughout the Coronavirus (COVID-19) crisis. As we follow the CDC guidelines and practice social distancing, we remain available for phone consultations and scheduled in-person meetings with both current and prospective clients and colleagues. Please contact our office by email or by calling 713-222-7211 with any questions. We look forward to hearing from you.

Posts tagged "dangerous drug"

New Dangers Found in Popular Sports Supplement

New reports surrounding the sports supplement Craze have caused concern throughout the athletic arena. Tests by scientists in the United States and South Korea have found, what they report to be, a chemical similar to methamphetamine in the popular sports supplement. According to the reports, researchers informed the Food and Drug Administration (FDA) in May that the chemical in Craze was very similar to methamphetamine which is a highly addictive, very powerful illegal stimulant drug.

Recent Johnson & Johnson Recalls

Johnson & Johnson, who has in the past experienced some serious concerns and questions with regards to its quality control, has again announce two recalls of popular consumer products in the space of one week - liquid Motrin for infants and Risperdal Consta. These two most recent recalls appear to be on products that are made (or their ingredients are made) by outside companies, leading one to again question the quality control of J &J.

Man Dies of Brain Hemorrhage from Taking Heart Medication

In 2009, at the age of 54, Jed Grisham began taking Plavix for the treatment of blockages in his arteries. Approximately two years later, Grisham suffered from a large left brain hemorrhage and died from his injuries.

Congress Looks to Strengthen Regulation of Compounding Pharmacies

In the wake of a recent deadly meningitis outbreak, the Senate Health, Education, Labor and Pensions (HELP) Committee will consider ways to strengthen regulation of drug compounding.

Avandia's Safety to be Reconsidered by the FDA

Once again the controversial diabetes drug rosiglitazone (Avandia) will be the subject of a 2 day Food and Drug Administration (FDA) hearing. The U.S. Food and Drug Administration is taking the unusual step of re-evaluating the evidence of safety risks from the once popular diabetes drug Avandia, whose sales were sharply restricted by the federal agency three years ago because of cardiovascular risks. The re-evaluation is to better assess the drug's safety.

Supreme Court to Hear Arguments Over Genetic Drug Maker Liability

The Supreme Court has agreed that it will hear a case regarding whether a generic drug maker can be held liable in product-liability lawsuit claiming a design defect.

FDA: Popular Antibiotic May Cause Fatal Heart Rhythms

According to a new warning from the Food and Drug Administration (FDA), a popular antibiotic used to treat bacterial infections can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm. The drug, azithromycin (Zithromax or Zmax), is commonly sold in what is called a Z-pak. The FDA reports that in 2011 alone, approximately 40.3 million individuals in the United States received an outpatient prescription for the macrolide azithromycin.

Family Receives Judgment Against Johnson & Johnson in Connection with Children's Motrin

A Massachusetts family has recently been awarded $63 million against Johnson & Johnson after a young girl suffered severe side effects from taking Children's Motrin. The family of Samantha Reckis will ultimately receive $109 million with interest as the injury occurred a decade ago.

Ranbaxy Pharmaceuticals Drug Recall

Dozens of lots of the generic version of the cholesterol drug Lipitor have been recalled because they may contain tiny glass particles. Ranbaxy Pharmaceuticals, a subsidiary of Ranbaxy Laboratories Ltd. is operating under increased scrutiny from the United States Food and Drug Administration (FDA) because of possible multiple quality lapses at several of its factories over the past several years.

The Dangers of Pradaxa

Pradaxa is a prescription drug taken by many as a blood thinner (anticoagulant). This blood-thinning medication lowers the chance of blood clots forming in the body. It is commonly used for individuals who have an irregular heartbeat called atrial fibrillation (AFib) when it not caused by a problem in the heart valve.

  • $50+ Million Personal Injury Fire and Explosion

    The firm successfully represented nearly 100 victims who suffered personal injuries and damages to property from a large fire and explosion resulting in a settlement of more than $50 million. The firm served as lead lawyers on the steering committee in this litigation.

  • $80 Million Personal Injury Large Plant Explosion

    The firm successfully represented 270 plaintiffs, taking a lead role in the plaintiffs’ steering committee, who suffered injuries in a large plant explosion resulting in a settlement of nearly $80 million.

  • $50+ Million Personal Injury Plant Fire and Explosion

    The firm successfully represented 45 personal injury victims in a plant fire and explosion, serving on the plaintiffs steering committee, concluding with a settlement of more than $50 million.

  • $22+ Million Personal Injury Work Site Accident

    The firm prevailed in a personal injury trial for a worksite injury client with the jury returning a verdict and resulting in a judgment of over $22 million for the firm’s client.

  • $12 Million Auto Accident 18-Wheeler Collision

    The firm successfully achieved a $12 million settlement for the family of a man who died in an 18 wheeler collision.

  • $30 Million Personal Injury Burn Victims

    The firm prevailed on behalf of three burn victims with settlements totaling nearly $30 million.

Our Record Of Success

When you are hurt and you choose a law firm to represent you in court or at the negotiation table, you need to carefully consider the firm's record.

Read More Success Stories

Let Us Help You Request a Free Consultation Today

Get Help Now

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Back to top